Background And Hypothesis: Maternal priming might enhance the beneficial nonspecific effects (NSEs) of live measles vaccination (MV). Children with a bacillus Calmette-Guérin (BCG) vaccine scar have a lower mortality rate than those without a scar that is not explained by protection against tuberculosis. We examined the hypothesis that BCG scarring would have a stronger effect on a child if the mother also had a BCG scar.

Methods: In a randomized controlled trial (RCT) of early MV in children aged 4.5 months, the BCG-scar status of the children and their mother were registered at enrollment at 4.5 months of age. The children were followed up until they were 36 months of age. Using a Cox proportional hazards model, we compared mortality rate ratios according to maternal and child BCG-scar status after adjusting for where the BCG vaccine was given (the national hospital or elsewhere). We censored for other interventions that have immunomodulating effects on child survival, including neonatal vitamin A supplementation and early MV.

Results: A total of 2213 children had not received neonatal vitamin A supplementation and early MV; 83% of these children and 44% of the mothers had a BCG scar. Children whose mother had a BCG scar were not more likely to have a BCG scar than those whose mother did not have a BCG scar (risk ratio, 1.01 [95% confidence interval (CI), 0.98-1.05]). Among the children, having a BCG scar was associated with a 41% (95% CI, 5%-64%) lower mortality between the ages of 4.5 and 36 months. The reduction in mortality was 66% (95% CI, 33%-83%) if the mother also had a BCG scar but only 8% (95% CI, -83% to 53%) if the mother had no BCG scar (test of interaction, P = .04).

Conclusions: Maternal BCG priming might be important for the effect of BCG vaccination on child survival. Ensuring better BCG vaccine scarring among mothers and children could have a considerable effect on child mortality levels.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jpids/piy142DOI Listing

Publication Analysis

Top Keywords

bcg scar
28
bcg vaccine
20
mother bcg
20
bcg
16
scar
10
children
9
maternal priming
8
bacillus calmette-guérin
8
calmette-guérin bcg
8
vaccine scarring
8

Similar Publications

Background And Methods: While leprosy primarily affects adults, childhood leprosy poses unique challenges because of its potential to cause lifelong disabilities and stigma. This is a retrospective record review of all patients aged 15 or below, diagnosed with leprosy, who were registered at the leprosy clinic of our tertiary care center from June 2014 to December 2023.

Results: As per hospital records, 1083 leprosy cases were registered at our center during the study period.

View Article and Find Full Text PDF

Some individuals, even when heavily exposed to an infectious tuberculosis patient, do not develop a specific T-cell response as measured by interferon-gamma release assay (IGRA). This could be explained by an IFN-γ-independent adaptive immune response, or an effective innate host response clearing Mycobacterium tuberculosis (Mtb) without adaptive immunity. In heavily exposed Indonesian tuberculosis household contacts (n = 1347), a persistently IGRA negative status was associated with presence of a BCG scar, and - especially among those with a BCG scar - with altered innate immune cells dynamics, higher heterologous (Escherichia coli-induced) proinflammatory cytokine production, and higher inflammatory proteins in the IGRA mitogen tube.

View Article and Find Full Text PDF

Purpose: Tuberculosis (TB) remains a significant public health concern globally. Bacille Calmette-Guérin (BCG) vaccination is widely used, but scar formation post-vaccination is not universal, which raises concerns about its efficacy. The Mantoux test is used to assess the immune response following BCG vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • - This review focuses on basal cell carcinoma (BCC) that develops in scar tissue, noting its rarity but clinical importance, and includes a specific case involving a patient with a BCG vaccination scar.
  • - It highlights the unclear mechanisms behind BCC growth associated with injury while emphasizing the need for further research to identify risk factors and improve understanding.
  • - The review discusses various treatment options for BCC, including surgery and new medications, and stresses the need for regular skin assessments in patients with scars or recent vaccinations to enhance early detection and management.
View Article and Find Full Text PDF
Article Synopsis
  • Skin scars from BCG or smallpox vaccinations are indicators of effective vaccination and are linked to both specific and broader health benefits.
  • Despite their long history of use, the mechanisms behind scar formation and the connection between local skin reactions and systemic health effects are still not fully understood.
  • This review explores current knowledge about skin events from these vaccines and their overall significance for human health, especially in maternal-child health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!